Aptamers Market research
The Aptamers Market has witnessed substantial growth over the past decade due to the rising adoption of aptamers in diagnostics and therapeutics. Aptamers are short nucleic acid sequences capable of binding specific targets with high affinity, often referred to as “chemical antibodies.” Compared to traditional antibodies, they offer advantages such as lower immunogenicity, cost-effective production, and enhanced stability.
Diagnostics remains a key driver. Aptamer-based biosensors and point-of-care devices provide rapid and accurate detection of biomarkers, crucial for early disease detection. In therapeutics, aptamers act as targeted inhibitors or drug delivery agents, especially in cancer and autoimmune disorders. North America leads the market, while Asia-Pacific shows the fastest growth due to rising healthcare investments. Challenges such as high production costs are mitigated by advancements in SELEX technology. Overall, the market is poised for robust expansion.